Tae-Hyun Kim Selected Research

Tae-Hyun Kim Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 05/2006
6	Inflammation (Inflammations) 01/2021 - 12/2002
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2014 - 02/2004
4	Type 2 Diabetes Mellitus (MODY) 05/2013 - 04/2005
4	Neoplasm Metastasis (Metastasis) 11/2010 - 04/2006
3	Status Epilepticus (Complex Partial Status Epilepticus) 05/2022 - 02/2021
3	Epilepsy (Aura) 04/2022 - 04/2021
3	Seizures (Absence Seizure) 04/2021 - 08/2020
3	Phototoxic Dermatitis (Phototoxicity) 10/2016 - 11/2013
3	Myoma 07/2015 - 07/2014
2	Necrosis 02/2021 - 06/2003
2	Osteoporosis 01/2021 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2020 - 02/2004
2	Melanoma (Melanoma, Malignant) 01/2020 - 08/2009
2	Wounds and Injuries (Trauma) 01/2020 - 01/2013
2	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2009
2	Dehydration (Water Stress) 01/2018 - 01/2016
2	Infections 01/2018 - 05/2011
2	Obesity 01/2018 - 03/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 05/2013
2	Insulin Resistance 01/2018 - 01/2012
2	Postoperative Pain 11/2015 - 07/2014
2	Adenomyosis 07/2015 - 04/2015
2	Glioma (Gliomas) 04/2006 - 03/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Drug Resistant Epilepsy 08/2021
1	Peritonitis 01/2021
1	Bone Resorption 01/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021
1	Hernia (Hernias) 10/2020
1	Incisional Hernia 10/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Body Weight Changes 01/2020
1	Pathologic Constriction (Stenosis) 01/2020

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 11/2021 - 03/2007
5	LigandsIBA 10/2016 - 06/2003
4	AcidsIBA 05/2022 - 08/2020
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2005
3	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
3	GoldIBA 10/2016 - 11/2013
3	Photosensitizing Agents (Photosensitizers)IBA 10/2016 - 09/2013
3	TrypsinIBA 06/2003 - 12/2002
2	bardoxolone methylIBA 05/2022 - 04/2022
2	AMPA Receptors (AMPA Receptor)IBA 08/2021 - 04/2021
2	perampanelIBA 08/2021 - 04/2021
2	GYKI 52466IBA 08/2021 - 04/2021
2	Glutamic Acid (Glutamate)FDA Link 04/2021 - 08/2020
2	Caspase 3 (Caspase-3)IBA 02/2021 - 01/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2021 - 01/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 01/2017
2	Insulin (Novolin)FDA Link 01/2018 - 01/2012
2	poly(ethylene glycol)-poly(aspartate hydrazide)IBA 10/2016 - 11/2013
2	hydroxide ionIBA 01/2016 - 01/2014
2	Biological ProductsIBA 09/2015 - 05/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2015 - 11/2013
2	EnzymesIBA 05/2011 - 01/2011
2	Proteinase-Activated ReceptorsIBA 12/2003 - 06/2003
2	Tryptases (Tryptase)IBA 07/2003 - 12/2002
2	PAR-2 ReceptorIBA 07/2003 - 12/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2003 - 12/2002
1	EstersIBA 05/2022
1	Dynamins (Dynamin)IBA 04/2022
1	Serine (L-Serine)FDA Link 04/2022
1	Glutathione (Reduced Glutathione)IBA 04/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2021
1	ParvalbuminsIBA 02/2021
1	HMGB1 Protein (HMG1)IBA 02/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	StrontiumIBA 01/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2021
1	Actins (F Actin)IBA 01/2021
1	Neurofibromin 2 (Merlin)IBA 01/2021
1	tartaric acid (tartrate)FDA Link 01/2021
1	S 10 (S-10)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Ligand-Gated Ion ChannelsIBA 08/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	1-methylnaphthaleneIBA 01/2020
1	Axitinib (AG 013736)IBA 01/2020
1	Biopolymers (Biopolymer)IBA 01/2020
1	PlatinumIBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2021 - 04/2006
5	Radiotherapy 12/2008 - 02/2004
4	Precision Medicine 01/2017 - 11/2013
4	Photochemotherapy (Photodynamic Therapy) 10/2016 - 09/2013
3	Hysterectomy 07/2015 - 10/2014
2	Suture Techniques 10/2020 - 07/2014
2	Proton Therapy 01/2020 - 09/2008
2	Fluid Therapy (Oral Rehydration Therapy) 01/2018 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 12/2008
2	Lasers (Laser) 10/2016 - 07/2015
2	Operative Time 11/2015 - 07/2014
2	Length of Stay 11/2015 - 07/2014
1	Sutures (Suture) 10/2020
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 10/2020